{"id":1018,"date":"2025-12-19T05:07:00","date_gmt":"2025-12-19T05:07:00","guid":{"rendered":"https:\/\/pharma-talks.com\/?post_type=episode&#038;p=1018"},"modified":"2026-09-03T14:54:40","modified_gmt":"2026-09-03T14:54:40","slug":"pharma-omnichannel-engagement","status":"publish","type":"episode","link":"https:\/\/pharma-talks.com\/episodes\/pharma-omnichannel-engagement\/","title":{"rendered":"Omnichannel Isn&#8217;t a Tech Problem: Yacin Marzouki on Pharma\u00a0"},"content":{"rendered":"\n<div style=\"height:200px\" aria-hidden=\"true\" class=\"wp-block-spacer\"><\/div>\n\n\n<style id=\"pharmatalks-content-section-style\">.pt-content-section{background:var(--pt-content-section-bg,transparent);color:var(--pt-content-section-text,var(--color-text));padding:var(--pt-content-section-padding-top,32px) var(--pt-content-section-padding-x,0) var(--pt-content-section-padding-bottom,32px)}.pt-content-section img{border-radius:24px}.pt-content-section>.container{max-width:var(--pt-content-section-container-max-width,var(--container-width));padding:var(--pt-content-section-container-padding-top,0) var(--pt-content-section-container-padding-x,var(--container-padding)) var(--pt-content-section-container-padding-bottom,0)}@media (max-width:899px){.pt-content-section{padding:var(--pt-content-section-mobile-padding-top,var(--pt-content-section-padding-top,32px)) var(--pt-content-section-mobile-padding-x,var(--pt-content-section-padding-x,0)) var(--pt-content-section-mobile-padding-bottom,var(--pt-content-section-padding-bottom,32px))}.pt-content-section>.container{padding:var(--pt-content-section-mobile-container-padding-top,var(--pt-content-section-container-padding-top,0)) var(--pt-content-section-mobile-container-padding-x,var(--pt-content-section-container-padding-x,var(--container-padding))) var(--pt-content-section-mobile-container-padding-bottom,var(--pt-content-section-container-padding-bottom,0))}}<\/style>\n<section class=\"wp-block-pharmatalks-content-section pt-content-section\" style=\"color:#082480;--pt-content-section-padding-top:32px;--pt-content-section-padding-bottom:32px;--pt-content-section-mobile-padding-top:16px;--pt-content-section-container-max-width:1240px;--pt-content-section-container-padding-top:0px;--pt-content-section-container-padding-bottom:0px\"><div class=\"container\">\n<figure class=\"wp-block-image size-full\"><img loading=\"lazy\" decoding=\"async\" src=\"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/09\/Podcast-How-Pharma-Should-Rethink-and-Mature-Its-Omnichannel-Engagement-1.png\" alt=\"\" class=\"wp-image-1019\" width=\"1200\" height=\"675\" srcset=\"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/09\/Podcast-How-Pharma-Should-Rethink-and-Mature-Its-Omnichannel-Engagement-1.png 1200w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/09\/Podcast-How-Pharma-Should-Rethink-and-Mature-Its-Omnichannel-Engagement-1-300x169.png 300w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/09\/Podcast-How-Pharma-Should-Rethink-and-Mature-Its-Omnichannel-Engagement-1-1024x576.png 1024w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/09\/Podcast-How-Pharma-Should-Rethink-and-Mature-Its-Omnichannel-Engagement-1-768x432.png 768w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/09\/Podcast-How-Pharma-Should-Rethink-and-Mature-Its-Omnichannel-Engagement-1-371x209.png 371w\" sizes=\"auto, (max-width: 1200px) 100vw, 1200px\" \/><\/figure>\n<\/div><\/section>\n\n\n\n<section class=\"wp-block-pharmatalks-content-section pt-content-section\" style=\"color:#082480;--pt-content-section-padding-top:32px;--pt-content-section-padding-bottom:32px;--pt-content-section-container-max-width:1280px;--pt-content-section-container-padding-top:0px;--pt-content-section-container-padding-bottom:0px\"><div class=\"container\">\n<section class=\"wp-block-pharmatalks-episode-player pt-episode-player\" style=\"color:#082480;--pt-episode-player-padding-top:0px;--pt-episode-player-padding-bottom:0px\"><div class=\"container\"><div class=\"pt-episode-player__inner\"><div class=\"pt-episode-player__media\"><img decoding=\"async\" src=\"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/02\/pt-logo-1.webp\" alt=\"Don\u2019t miss a new episode\" loading=\"lazy\"\/><\/div><div class=\"pt-episode-player__content\"><p class=\"pt-episode-player__subtitle\">Omnichannel Isn&#8217;t a Tech Problem: Yacin Marzouki on Pharma<\/p><h3 class=\"pt-episode-player__title\">Don\u2019t miss a new episode<\/h3><div class=\"pt-episode-player__controls\"><button type=\"button\" class=\"pt-episode-player__play\" aria-label=\"Play\" aria-pressed=\"false\"><span class=\"pt-episode-player__play-icon\" aria-hidden=\"true\"><\/span><\/button><div class=\"pt-episode-player__panel\"><div class=\"pt-episode-player__timeline\"><input type=\"range\" class=\"pt-episode-player__progress\" min=\"0\" max=\"100\" step=\"0.1\" defaultvalue=\"0\" aria-label=\"Seek\"\/><\/div><div class=\"pt-episode-player__bottom\"><div class=\"pt-episode-player__actions\"><button type=\"button\" class=\"pt-episode-player__speed pt-episode-player__speed--down\" data-speed=\"down\" aria-label=\"Slow down\"><span class=\"pt-episode-player__speed-icon\" aria-hidden=\"true\"><\/span><\/button><span class=\"pt-episode-player__speed-display\">1X<\/span><button type=\"button\" class=\"pt-episode-player__speed pt-episode-player__speed--up\" data-speed=\"up\" aria-label=\"Speed up\"><span class=\"pt-episode-player__speed-icon\" aria-hidden=\"true\"><\/span><\/button><\/div><div class=\"pt-episode-player__time-volume\"><div class=\"pt-episode-player__volume\"><button type=\"button\" class=\"pt-episode-player__volume-toggle\" aria-label=\"Mute\" aria-pressed=\"false\"><span class=\"pt-episode-player__volume-icon\" aria-hidden=\"true\"><\/span><\/button><input type=\"range\" class=\"pt-episode-player__volume-range\" min=\"0\" max=\"1\" step=\"0.01\" defaultvalue=\"1\" aria-label=\"Volume\"\/><\/div><div class=\"pt-episode-player__time\"><span class=\"pt-episode-player__current\">0:00<\/span><span class=\"pt-episode-player__divider\">|<\/span><span class=\"pt-episode-player__duration\">&#8211;:&#8211;<\/span><\/div><\/div><\/div><\/div><\/div><div class=\"pt-episode-player__links\"><a class=\"pt-episode-player__link\" href=\"#subscribe\" rel=\"noopener noreferrer\">Subscribe<\/a><\/div><audio class=\"pt-episode-player__audio\" src=\"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/09\/How-Pharma-Must-Rethink-Omnichannel-Engagement-_-Pharma-Talks.mp3\"><\/audio><\/div><\/div><\/div><\/section>\n<\/div><\/section>\n\n\n\n<section class=\"wp-block-pharmatalks-content-section pt-content-section\" style=\"color:#082480;--pt-content-section-padding-top:32px;--pt-content-section-padding-bottom:32px;--pt-content-section-mobile-padding-x:20px;--pt-content-section-container-max-width:1200px;--pt-content-section-container-padding-top:20px;--pt-content-section-container-padding-bottom:20px;--pt-content-section-container-padding-x:20px\"><div class=\"container\" style=\"border-radius:20px;overflow:hidden;background-color:#ffffff\">\n<p class=\"wp-block-paragraph\">Retail wrote the omnichannel playbook in the early 2000s. Pharma arrived much later, and to a harder version of the problem \u2014 one where the output affects patient outcomes and the rules from telecom and retail don&#8217;t transfer cleanly.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In this episode of Pharma Talks, Nataliya Andreychuk spoke with Yacin Marzouki, who has built omnichannel programs across Japan, EMEA, and South America. He&#8217;s launched HCP portals that worked and portals that didn&#8217;t, and he&#8217;s specific about which was which.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">His core position: pharma doesn&#8217;t need more channels or more technology. It needs alignment and a real understanding of its audiences.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>The Fragmentation Problem<\/strong>&nbsp;<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Asked about blind spots, Yacin&#8217;s answer starts by rejecting the framing. It isn&#8217;t a technology problem.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In retail, one function typically owns omnichannel end to end \u2014 the stack, the CRM, content creation, campaign execution, and the insight loop that feeds back into all of it.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Pharma splits that across teams. Marketing creates content without owning the tech stack. Omnichannel teams run the stack without creating content. Analytics sits in its own lane. Medical approves content without being aligned on segmentation goals. Data silos follow structurally, and personalization gets harder as a result.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The second blind spot is more fundamental:&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">In life sciences, we need to get clear on who the actual customer is. We obsess over what HCPs supposedly want. But HCPs don&#8217;t make decisions in a vacuum. They manage institutional pressures, payer rules, and patient anxieties. If we don&#8217;t equip them with the information they need to convince patients, our content delivers zero real value.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The third: teams collect data, interpret it separately, and never consolidate it into one narrative. Which leaves marketers without a reliable basis for deciding what to do next.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Faster Horses<\/strong>&nbsp;<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Plenty of brands describe themselves as customer-centric while doing something narrower \u2014 asking the audience what it wants without understanding the situation the answer comes from.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Yacin&#8217;s argument is to stop asking HCPs what they need. It&#8217;s the 1900 question about faster horses. The useful questions look different:&nbsp;<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Where do they actually access information today?&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>What problems are they hitting with patients?&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>What are they searching for?&nbsp;<\/li>\n<\/ul>\n\n\n\n<ul class=\"wp-block-list\">\n<li>What questions do patients keep bringing them?&nbsp;<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">The reframe underneath all four: the job isn&#8217;t only convincing HCPs. It&#8217;s giving HCPs what they need to convince patients, who are making the decision.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>What Maturity Actually Looks Like<\/strong>&nbsp;<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Omnichannel has a definition problem. People picture the end state \u2014 right message, right time, right channel \u2014 and treat that as the strategy. It&#8217;s the outcome.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Yacin&#8217;s stages run from face-to-face only, through basic activation with a few added channels, to multichannel, then omnichannel, then advanced or predictive omnichannel.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Multichannel gets dismissed unfairly. Executed well, it works. Nataliya&#8217;s own approach is the example he reaches for \u2014 audience trust built across channels over time, with the podcast added once the foundation existed.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">The podcast isn&#8217;t fully integrated into your ecosystem, and you can&#8217;t track whether Dr. Anna watched it for 30 minutes. But that&#8217;s completely OK. It still delivers value. And when you consistently deliver value, you earn the right for deeper interactions later.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">His point about attribution follows from the same logic. No decision comes from one channel.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">I&#8217;m sure there were multiple &#8220;aha moments&#8221; before you, Nataliya, bought your glasses. HCP decisions work the same way.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Why It Gets Expensive<\/strong>&nbsp;<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Maturity raises costs on both sides \u2014 the stack and the content plan. Segmentation only produces value if you actually make content for each segment.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Five personas and one email is zero personalization. Five personas and five emails lifts engagement, and lifts cost and approval load with it. Medical teams frequently don&#8217;t have capacity to clear that volume, which is why the plan has to be built jointly. Otherwise you produce five and ship one.&nbsp;<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>The Content That Never Arrives<\/strong>&nbsp;<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Even approved content stalls. The episode cites 77% of content never reaching HCPs \u2014 not because it&#8217;s poor, but because reps aren&#8217;t comfortable presenting it. Without understanding the persona it was built for, they revert to the deck they know.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Nataliya&#8217;s addition:&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Segmentation is often too generic. If the content doesn&#8217;t match the conversation, it never gets used.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Agencies working without HCP-level data can only personalize at the surface, which is why more pharma companies are building digital personas. But the value of that varies by market. In Spain, where HCP engagement is regular and digital, personas are grounded in something. In Germany, where reps might see an HCP once or twice a year and email open rates run lower, personalization rests on assumption.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Hot or Not<\/strong>&nbsp;<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Nataliya&#8217;s rapid-fire round, and where Yacin landed:&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>More platforms equal better omnichannel<\/strong> \u2014 Not.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>AI will outperform humans in segmentation by 2026<\/strong> \u2014 Hot, but only if real value follows.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Rep-triggered engagement will beat mass email<\/strong> \u2014 Hot.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Omnichannel starts with content, not data<\/strong> \u2014 Hot.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>HCPs want personalization, not promotion<\/strong> \u2014 Very hot.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Global should own strategy, local should execute<\/strong> \u2014 Lukewarm.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>The future is fewer but smarter channels<\/strong> \u2014 Hot.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>PDFs will disappear by 2027<\/strong> \u2014 &#8220;No chance. There are still fax machines in Germany.&#8221;&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Omnichannel will merge with medcomms and patient engagement by 2030<\/strong> \u2014 Hot.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>The next frontier is emotional tech, empathy, and trust<\/strong> \u2014 Hot.&nbsp;<\/p>\n\n\n\n<h2 class=\"wp-block-heading\"><strong>Getting It Right<\/strong>&nbsp;<\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Technology alone doesn&#8217;t fix omnichannel. What does is teams sharing data continuously, testing, and checking findings against what they actually know about their audiences.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">And the audience isn&#8217;t only HCPs. Once that&#8217;s clear, the work becomes asking better questions \u2014 the kind that come from empathy rather than from an agenda. That&#8217;s the shift from treating omnichannel as a department to treating it as an ecosystem.&nbsp;<\/p>\n<\/div><\/section>\n\n\n<section class=\"pt-related-episodes\" style=\"--pt-related-bg:#264cb8;color:#082480;--pt-related-title-color:#eff2ef;--pt-related-padding-top:50px;--pt-related-padding-bottom:60px;--pt-related-padding-x:0px\">\n            <div class=\"container\">\n                        <div class=\"pt-related-episodes__header\">\n                <h2 class=\"pt-related-episodes__title\">Our Latest Pharma Talk Episodes<\/h2>\n            <\/div>\n                <div class=\"pt-related-episodes__grid\">\n                                        <article class=\"pt-episode-card\">\n                    <a class=\"pt-episode-card__image\" href=\"https:\/\/pharma-talks.com\/episodes\/pharma-omnichannel-engagement\/\">\n                                                    <img width=\"371\" height=\"209\" src=\"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/09\/Podcast-How-Pharma-Should-Rethink-and-Mature-Its-Omnichannel-Engagement-1-371x209.png\" class=\"attachment-pharmatalks-related-card size-pharmatalks-related-card\" alt=\"\" loading=\"lazy\" decoding=\"async\" sizes=\"auto, (max-width: 640px) 100vw, (max-width: 1024px) 50vw, 371px\" srcset=\"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/09\/Podcast-How-Pharma-Should-Rethink-and-Mature-Its-Omnichannel-Engagement-1-371x209.png 371w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/09\/Podcast-How-Pharma-Should-Rethink-and-Mature-Its-Omnichannel-Engagement-1-300x169.png 300w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/09\/Podcast-How-Pharma-Should-Rethink-and-Mature-Its-Omnichannel-Engagement-1-1024x576.png 1024w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/09\/Podcast-How-Pharma-Should-Rethink-and-Mature-Its-Omnichannel-Engagement-1-768x432.png 768w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/09\/Podcast-How-Pharma-Should-Rethink-and-Mature-Its-Omnichannel-Engagement-1.png 1200w\" \/>                                            <\/a>\n                    <div class=\"pt-episode-card__body\">\n                        <p class=\"pt-episode-card__meta\">December 19, 2025<span class=\"pt-episode-card__duration\">7 min read<\/span><\/p>\n                        <h4 class=\"pt-episode-card__title\">\n                            <a href=\"https:\/\/pharma-talks.com\/episodes\/pharma-omnichannel-engagement\/\">Omnichannel Isn&#8217;t a Tech Problem: Yacin Marzouki on Pharma\u00a0<\/a>\n                        <\/h4>\n                        <div class=\"pt-episode-card__detail\"><p class=\"pt-episode-card__guest-label\">Guest<\/p><p class=\"pt-episode-card__guest-name\">Yacin Marzouki<\/p><div class=\"pt-episode-card__guest-meta\"><p class=\"pt-episode-card__guest-meta-position\">Omnichannel &amp; customer<\/p><p class=\"pt-episode-card__guest-meta-company\">engagement expert<\/p><\/div><div class=\"pt-episode-card__actions\"><a class=\"pt-episode-card__listen\" href=\"https:\/\/pharma-talks.com\/episodes\/pharma-omnichannel-engagement\/\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"pt-episode-card__play-icon\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" aria-hidden=\"true\" focusable=\"false\"><path d=\"M15.3744 12.7588L14.8288 11.9208L14.8148 11.9298L14.8012 11.9394L15.3744 12.7588ZM15.3744 11.4687L14.7814 12.2739L14.826 12.3068L14.874 12.3345L15.3744 11.4687ZM10.2037 7.66122L10.7966 6.85597L10.7684 6.8352L10.7388 6.81644L10.2037 7.66122ZM9.11966 8.22991L10.1197 8.22701L10.1196 8.21826L10.1194 8.2095L9.11966 8.22991ZM9.14134 15.709L8.14134 15.7119L8.14142 15.7402L8.14311 15.7684L9.14134 15.709ZM10.2651 16.3323L10.7493 17.2072L10.7952 17.1818L10.8382 17.1517L10.2651 16.3323ZM12 21V20C7.58172 20 4 16.4183 4 12H3H2C2 17.5228 6.47715 22 12 22V21ZM21 12H20C20 16.4183 16.4183 20 12 20V21V22C17.5228 22 22 17.5228 22 12H21ZM12 3V4C16.4183 4 20 7.58172 20 12H21H22C22 6.47715 17.5228 2 12 2V3ZM12 3V2C6.47715 2 2 6.47715 2 12H3H4C4 7.58172 7.58172 4 12 4V3ZM15.3744 12.7588L15.9199 13.5969C16.3323 13.3285 16.8704 12.8393 16.8694 12.0938C16.8683 11.3258 16.3021 10.8499 15.8747 10.6029L15.3744 11.4687L14.874 12.3345C14.9677 12.3886 14.9787 12.4133 14.9586 12.3878C14.9315 12.3532 14.8696 12.2512 14.8694 12.0965C14.8692 11.9454 14.928 11.8534 14.9423 11.8342C14.952 11.821 14.9295 11.8552 14.8288 11.9208L15.3744 12.7588ZM15.3744 11.4687L15.9673 10.6634L10.7966 6.85597L10.2037 7.66122L9.61072 8.46646L14.7814 12.2739L15.3744 11.4687ZM10.2037 7.66122L10.7388 6.81644C10.286 6.52965 9.64347 6.36117 9.03218 6.6466C8.36565 6.95781 8.10714 7.62689 8.11987 8.25032L9.11966 8.22991L10.1194 8.2095C10.1185 8.16275 10.1285 8.19137 10.0938 8.25775C10.0552 8.33159 9.98183 8.41046 9.87832 8.45879C9.67864 8.55202 9.5853 8.45326 9.66854 8.50599L10.2037 7.66122ZM9.11966 8.22991L8.11966 8.23281L8.14134 15.7119L9.14134 15.709L10.1413 15.7061L10.1197 8.22701L9.11966 8.22991ZM9.14134 15.709L8.14311 15.7684C8.17339 16.2771 8.35111 16.9731 9.00854 17.3242C9.65564 17.6698 10.3249 17.4421 10.7493 17.2072L10.2651 16.3323L9.78087 15.4573C9.69245 15.5063 9.66333 15.5057 9.68777 15.5024C9.72022 15.4979 9.82562 15.4933 9.95074 15.5601C10.0775 15.6278 10.1348 15.7209 10.1513 15.7559C10.1634 15.7818 10.146 15.758 10.1396 15.6496L9.14134 15.709ZM10.2651 16.3323L10.8382 17.1517L15.9475 13.5783L15.3744 12.7588L14.8012 11.9394L9.69195 15.5128L10.2651 16.3323Z\" fill=\"#EFF2EF\"\/><\/svg><span class=\"pt-episode-card__listen-text\">Listen Now!<\/span><\/a><\/div><\/div>                    <\/div>\n                <\/article>\n                                        <article class=\"pt-episode-card\">\n                    <a class=\"pt-episode-card__image\" href=\"https:\/\/pharma-talks.com\/episodes\/ai-in-pharma-communication\/\">\n                                                    <img width=\"371\" height=\"209\" src=\"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Talks-AI-and-Asia-What-Pharma-Marketers-Need-to-Hear-Right-Now-2-371x209.png\" class=\"attachment-pharmatalks-related-card size-pharmatalks-related-card\" alt=\"\" loading=\"lazy\" decoding=\"async\" sizes=\"auto, (max-width: 640px) 100vw, (max-width: 1024px) 50vw, 371px\" srcset=\"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Talks-AI-and-Asia-What-Pharma-Marketers-Need-to-Hear-Right-Now-2-371x209.png 371w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Talks-AI-and-Asia-What-Pharma-Marketers-Need-to-Hear-Right-Now-2-300x169.png 300w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Talks-AI-and-Asia-What-Pharma-Marketers-Need-to-Hear-Right-Now-2-1024x576.png 1024w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Talks-AI-and-Asia-What-Pharma-Marketers-Need-to-Hear-Right-Now-2-768x432.png 768w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Talks-AI-and-Asia-What-Pharma-Marketers-Need-to-Hear-Right-Now-2-1536x864.png 1536w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Talks-AI-and-Asia-What-Pharma-Marketers-Need-to-Hear-Right-Now-2-2048x1152.png 2048w\" \/>                                            <\/a>\n                    <div class=\"pt-episode-card__body\">\n                        <p class=\"pt-episode-card__meta\">May 29, 2026<span class=\"pt-episode-card__duration\">12 min read<\/span><\/p>\n                        <h4 class=\"pt-episode-card__title\">\n                            <a href=\"https:\/\/pharma-talks.com\/episodes\/ai-in-pharma-communication\/\">Why Western Campaign Logic Breaks in Asian Markets\u00a0<\/a>\n                        <\/h4>\n                        <div class=\"pt-episode-card__detail\"><p class=\"pt-episode-card__guest-label\">Guest<\/p><p class=\"pt-episode-card__guest-name\">Gwenael Meneux, Bruno Senouci<\/p><div class=\"pt-episode-card__guest-meta\"><p class=\"pt-episode-card__guest-meta-position\">CO-CEO, CO-CEO<\/p><p class=\"pt-episode-card__guest-meta-company\">drcom<\/p><\/div><div class=\"pt-episode-card__actions\"><a class=\"pt-episode-card__listen\" href=\"https:\/\/pharma-talks.com\/episodes\/ai-in-pharma-communication\/\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"pt-episode-card__play-icon\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" aria-hidden=\"true\" focusable=\"false\"><path d=\"M15.3744 12.7588L14.8288 11.9208L14.8148 11.9298L14.8012 11.9394L15.3744 12.7588ZM15.3744 11.4687L14.7814 12.2739L14.826 12.3068L14.874 12.3345L15.3744 11.4687ZM10.2037 7.66122L10.7966 6.85597L10.7684 6.8352L10.7388 6.81644L10.2037 7.66122ZM9.11966 8.22991L10.1197 8.22701L10.1196 8.21826L10.1194 8.2095L9.11966 8.22991ZM9.14134 15.709L8.14134 15.7119L8.14142 15.7402L8.14311 15.7684L9.14134 15.709ZM10.2651 16.3323L10.7493 17.2072L10.7952 17.1818L10.8382 17.1517L10.2651 16.3323ZM12 21V20C7.58172 20 4 16.4183 4 12H3H2C2 17.5228 6.47715 22 12 22V21ZM21 12H20C20 16.4183 16.4183 20 12 20V21V22C17.5228 22 22 17.5228 22 12H21ZM12 3V4C16.4183 4 20 7.58172 20 12H21H22C22 6.47715 17.5228 2 12 2V3ZM12 3V2C6.47715 2 2 6.47715 2 12H3H4C4 7.58172 7.58172 4 12 4V3ZM15.3744 12.7588L15.9199 13.5969C16.3323 13.3285 16.8704 12.8393 16.8694 12.0938C16.8683 11.3258 16.3021 10.8499 15.8747 10.6029L15.3744 11.4687L14.874 12.3345C14.9677 12.3886 14.9787 12.4133 14.9586 12.3878C14.9315 12.3532 14.8696 12.2512 14.8694 12.0965C14.8692 11.9454 14.928 11.8534 14.9423 11.8342C14.952 11.821 14.9295 11.8552 14.8288 11.9208L15.3744 12.7588ZM15.3744 11.4687L15.9673 10.6634L10.7966 6.85597L10.2037 7.66122L9.61072 8.46646L14.7814 12.2739L15.3744 11.4687ZM10.2037 7.66122L10.7388 6.81644C10.286 6.52965 9.64347 6.36117 9.03218 6.6466C8.36565 6.95781 8.10714 7.62689 8.11987 8.25032L9.11966 8.22991L10.1194 8.2095C10.1185 8.16275 10.1285 8.19137 10.0938 8.25775C10.0552 8.33159 9.98183 8.41046 9.87832 8.45879C9.67864 8.55202 9.5853 8.45326 9.66854 8.50599L10.2037 7.66122ZM9.11966 8.22991L8.11966 8.23281L8.14134 15.7119L9.14134 15.709L10.1413 15.7061L10.1197 8.22701L9.11966 8.22991ZM9.14134 15.709L8.14311 15.7684C8.17339 16.2771 8.35111 16.9731 9.00854 17.3242C9.65564 17.6698 10.3249 17.4421 10.7493 17.2072L10.2651 16.3323L9.78087 15.4573C9.69245 15.5063 9.66333 15.5057 9.68777 15.5024C9.72022 15.4979 9.82562 15.4933 9.95074 15.5601C10.0775 15.6278 10.1348 15.7209 10.1513 15.7559C10.1634 15.7818 10.146 15.758 10.1396 15.6496L9.14134 15.709ZM10.2651 16.3323L10.8382 17.1517L15.9475 13.5783L15.3744 12.7588L14.8012 11.9394L9.69195 15.5128L10.2651 16.3323Z\" fill=\"#EFF2EF\"\/><\/svg><span class=\"pt-episode-card__listen-text\">Listen Now!<\/span><\/a><\/div><\/div>                    <\/div>\n                <\/article>\n                                        <article class=\"pt-episode-card\">\n                    <a class=\"pt-episode-card__image\" href=\"https:\/\/pharma-talks.com\/episodes\/future-of-pharma-content\/\">\n                                                    <img width=\"371\" height=\"209\" src=\"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Content-AI_-Whats-Next_-_-Pharma-Talks-1-371x209.png\" class=\"attachment-pharmatalks-related-card size-pharmatalks-related-card\" alt=\"\" loading=\"lazy\" decoding=\"async\" sizes=\"auto, (max-width: 640px) 100vw, (max-width: 1024px) 50vw, 371px\" srcset=\"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Content-AI_-Whats-Next_-_-Pharma-Talks-1-371x209.png 371w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Content-AI_-Whats-Next_-_-Pharma-Talks-1-300x169.png 300w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Content-AI_-Whats-Next_-_-Pharma-Talks-1-1024x576.png 1024w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Content-AI_-Whats-Next_-_-Pharma-Talks-1-768x432.png 768w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Content-AI_-Whats-Next_-_-Pharma-Talks-1-1536x864.png 1536w, https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/05\/Pharma-Content-AI_-Whats-Next_-_-Pharma-Talks-1-2048x1152.png 2048w\" \/>                                            <\/a>\n                    <div class=\"pt-episode-card__body\">\n                        <p class=\"pt-episode-card__meta\">May 21, 2026<span class=\"pt-episode-card__duration\">8 min read<\/span><\/p>\n                        <h4 class=\"pt-episode-card__title\">\n                            <a href=\"https:\/\/pharma-talks.com\/episodes\/future-of-pharma-content\/\">Relevance, Not Volume: Tim Pantello on Pharma Content\u00a0<\/a>\n                        <\/h4>\n                        <div class=\"pt-episode-card__detail\"><p class=\"pt-episode-card__guest-label\">Guest<\/p><p class=\"pt-episode-card__guest-name\">Tim Pantello<\/p><div class=\"pt-episode-card__guest-meta\"><p class=\"pt-episode-card__guest-meta-position\">Chief Executive Officer<\/p><p class=\"pt-episode-card__guest-meta-company\">Relevate Health<\/p><\/div><div class=\"pt-episode-card__actions\"><a class=\"pt-episode-card__listen\" href=\"https:\/\/pharma-talks.com\/episodes\/future-of-pharma-content\/\"><svg xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"pt-episode-card__play-icon\" width=\"24\" height=\"24\" viewBox=\"0 0 24 24\" fill=\"none\" aria-hidden=\"true\" focusable=\"false\"><path d=\"M15.3744 12.7588L14.8288 11.9208L14.8148 11.9298L14.8012 11.9394L15.3744 12.7588ZM15.3744 11.4687L14.7814 12.2739L14.826 12.3068L14.874 12.3345L15.3744 11.4687ZM10.2037 7.66122L10.7966 6.85597L10.7684 6.8352L10.7388 6.81644L10.2037 7.66122ZM9.11966 8.22991L10.1197 8.22701L10.1196 8.21826L10.1194 8.2095L9.11966 8.22991ZM9.14134 15.709L8.14134 15.7119L8.14142 15.7402L8.14311 15.7684L9.14134 15.709ZM10.2651 16.3323L10.7493 17.2072L10.7952 17.1818L10.8382 17.1517L10.2651 16.3323ZM12 21V20C7.58172 20 4 16.4183 4 12H3H2C2 17.5228 6.47715 22 12 22V21ZM21 12H20C20 16.4183 16.4183 20 12 20V21V22C17.5228 22 22 17.5228 22 12H21ZM12 3V4C16.4183 4 20 7.58172 20 12H21H22C22 6.47715 17.5228 2 12 2V3ZM12 3V2C6.47715 2 2 6.47715 2 12H3H4C4 7.58172 7.58172 4 12 4V3ZM15.3744 12.7588L15.9199 13.5969C16.3323 13.3285 16.8704 12.8393 16.8694 12.0938C16.8683 11.3258 16.3021 10.8499 15.8747 10.6029L15.3744 11.4687L14.874 12.3345C14.9677 12.3886 14.9787 12.4133 14.9586 12.3878C14.9315 12.3532 14.8696 12.2512 14.8694 12.0965C14.8692 11.9454 14.928 11.8534 14.9423 11.8342C14.952 11.821 14.9295 11.8552 14.8288 11.9208L15.3744 12.7588ZM15.3744 11.4687L15.9673 10.6634L10.7966 6.85597L10.2037 7.66122L9.61072 8.46646L14.7814 12.2739L15.3744 11.4687ZM10.2037 7.66122L10.7388 6.81644C10.286 6.52965 9.64347 6.36117 9.03218 6.6466C8.36565 6.95781 8.10714 7.62689 8.11987 8.25032L9.11966 8.22991L10.1194 8.2095C10.1185 8.16275 10.1285 8.19137 10.0938 8.25775C10.0552 8.33159 9.98183 8.41046 9.87832 8.45879C9.67864 8.55202 9.5853 8.45326 9.66854 8.50599L10.2037 7.66122ZM9.11966 8.22991L8.11966 8.23281L8.14134 15.7119L9.14134 15.709L10.1413 15.7061L10.1197 8.22701L9.11966 8.22991ZM9.14134 15.709L8.14311 15.7684C8.17339 16.2771 8.35111 16.9731 9.00854 17.3242C9.65564 17.6698 10.3249 17.4421 10.7493 17.2072L10.2651 16.3323L9.78087 15.4573C9.69245 15.5063 9.66333 15.5057 9.68777 15.5024C9.72022 15.4979 9.82562 15.4933 9.95074 15.5601C10.0775 15.6278 10.1348 15.7209 10.1513 15.7559C10.1634 15.7818 10.146 15.758 10.1396 15.6496L9.14134 15.709ZM10.2651 16.3323L10.8382 17.1517L15.9475 13.5783L15.3744 12.7588L14.8012 11.9394L9.69195 15.5128L10.2651 16.3323Z\" fill=\"#EFF2EF\"\/><\/svg><span class=\"pt-episode-card__listen-text\">Listen Now!<\/span><\/a><\/div><\/div>                    <\/div>\n                <\/article>\n                    <\/div>\n            <\/div>\n    <\/section>\n\n\n<style id=\"pharmatalks-content-split-style\">.pt-split__container.container{max-width:var(--pt-split-container-width,var(--container-width))}@media (width >= 1440px){.pt-split__container.container{overflow:hidden}}.pt-split{background-color:var(--pt-split-bg,transparent);background-repeat:var(--pt-split-bg-repeat,no-repeat);padding-bottom:var(--pt-split-padding-bottom,64px);padding-top:var(--pt-split-padding-top,64px)}.pt-split figure{margin:0}.pt-split__inner{display:flex;flex-direction:column;gap:var(--pt-split-mobile-gap,var(--pt-split-gap,120px))}@media (width >= 1440px){.pt-split__inner{margin:0 -20px}}.pt-split__inner .pt-split__col{height:fit-content}.pt-split__col--left{background-color:var(--pt-split-col-left-color,transparent);background-image:var(--pt-split-col-left-image,none);background-position:var(--pt-split-col-left-pos,center);background-repeat:var(--pt-split-col-left-repeat,no-repeat);background-size:var(--pt-split-col-left-size,auto);border-radius:var(--pt-split-col-left-border-radius,0);padding:var(--pt-split-col-left-padding-top,0) var(--pt-split-col-left-padding-right,0) var(--pt-split-col-left-padding-bottom,0) var(--pt-split-col-left-padding-left,0)}.pt-split__col--right{background-color:var(--pt-split-col-right-color,transparent);background-image:var(--pt-split-col-right-image,none);background-position:var(--pt-split-col-right-pos,center);background-repeat:var(--pt-split-col-right-repeat,no-repeat);background-size:var(--pt-split-col-right-size,auto);border-radius:var(--pt-split-col-right-border-radius,0);padding:var(--pt-split-col-right-padding-top,0) var(--pt-split-col-right-padding-right,0) var(--pt-split-col-right-padding-bottom,0) var(--pt-split-col-right-padding-left,0)}@media (min-width:998px){.pt-split__inner{gap:var(--pt-split-gap,120px)}}@media (max-width:997px){.pt-split{padding-bottom:var(--pt-split-mobile-padding-bottom,var(--pt-split-padding-bottom,64px));padding-top:var(--pt-split-mobile-padding-top,var(--pt-split-padding-top,64px))}.pt-split__col--left{padding:var(--pt-split-col-left-mobile-padding-top,var(--pt-split-col-left-padding-top,0)) var(--pt-split-col-left-mobile-padding-right,var(--pt-split-col-left-padding-right,0)) var(--pt-split-col-left-mobile-padding-bottom,var(--pt-split-col-left-padding-bottom,0)) var(--pt-split-col-left-mobile-padding-left,var(--pt-split-col-left-padding-left,0))}.pt-split__col--right{padding:var(--pt-split-col-right-mobile-padding-top,var(--pt-split-col-right-padding-top,0)) var(--pt-split-col-right-mobile-padding-right,var(--pt-split-col-right-padding-right,0)) var(--pt-split-col-right-mobile-padding-bottom,var(--pt-split-col-right-padding-bottom,0)) var(--pt-split-col-right-mobile-padding-left,var(--pt-split-col-right-padding-left,0))}.pt-split--mobile-left-top .pt-split__col--left{order:1}.pt-split--mobile-left-top .pt-split__col--right,.pt-split--mobile-right-top .pt-split__col--left{order:2}.pt-split--mobile-right-top .pt-split__col--right{order:1}.pt-split__inner .wp-block-image img{margin:0 auto}}@media (min-width:998px){.pt-split__inner{display:flex;flex-direction:row}.align-bottom .pt-split__inner{align-items:flex-end}.pt-split__col--left{flex:var(--pt-split-left-ratio,40) 1 0;min-width:0}.pt-split__col--right{flex:var(--pt-split-right-ratio,60) 1 0;max-width:var(--pt-split-right-max-width,none);min-width:0}.pt-split__col--right .pt-split__col--right-container,.pt-split__col--right>.wp-block-group__inner-container{max-width:100%}.pt-split--desktop-right-left .pt-split__col--left{order:2}.pt-split--desktop-right-left .pt-split__col--right{order:1}}<\/style>\n<section class=\"wp-block-pharmatalks-content-split pt-split pt-split--mobile-left-top pt-split--desktop-left-right\" style=\"--pt-split-gap:48px;--pt-split-padding-top:64px;--pt-split-padding-bottom:64px;--pt-split-left-ratio:28;--pt-split-right-ratio:72;--pt-split-container-width:1240px;color:#082480;--pt-split-col-left-color:#274db800;--pt-split-col-left-image:url(https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/08\/bg-pharma.png);--pt-split-col-left-size:cover;--pt-split-col-left-pos:center;--pt-split-col-left-repeat:no-repeat;--pt-split-col-left-padding-top:52px;--pt-split-col-left-padding-right:63px;--pt-split-col-left-padding-bottom:63px;--pt-split-col-left-padding-left:44px;--pt-split-col-left-border-radius:16px;--pt-split-col-right-padding-top:0px;--pt-split-col-right-padding-right:0px;--pt-split-col-right-padding-bottom:0px;--pt-split-col-right-padding-left:0px;--pt-split-col-right-border-radius:0px\"><div class=\"container pt-split__container\"><div class=\"pt-split__inner\">\n<div id=\"subscribe\" class=\"wp-block-group pt-split__col pt-split__col--left\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<h2 class=\"wp-block-pharmatalks-split-heading pt-split-heading pt-split-heading--base pt-split-heading__inner\" style=\"--pt-split-heading-fs:56px;--pt-split-heading-fs-mobile:36px;--pt-split-heading-color:#264cb8;--pt-split-heading-mb:8px;--pt-split-heading-lh:1.2;--pt-split-heading-fw:500\">Subscribe<\/h2>\n\n\n\n<div class=\"wp-block-pharmatalks-split-text pt-split-text pt-split-text--base\" style=\"--pt-split-text-fs:18px;--pt-split-text-color:#082480;--pt-split-text-mb:24px;--pt-split-text-lh:1.2\"><div class=\"pt-split-text__inner\">To Get Pharma Talks Episodes Straight To Your Inbox.<\/div><\/div>\n\n\n\n<div class=\"wpcf7 no-js\" id=\"wpcf7-f96-o1\" lang=\"en-US\" dir=\"ltr\" data-wpcf7-id=\"96\">\n<div class=\"screen-reader-response\"><p role=\"status\" aria-live=\"polite\" aria-atomic=\"true\"><\/p> <ul><\/ul><\/div>\n<form action=\"\/?rest_route=%2Fwp%2Fv2%2Fepisode%2F1018#wpcf7-f96-o1\" method=\"post\" class=\"wpcf7-form init\" id=\"96\" aria-label=\"Contact form\" novalidate=\"novalidate\" data-status=\"init\">\n<fieldset class=\"hidden-fields-container\"><input type=\"hidden\" name=\"_wpcf7\" value=\"96\" \/><input type=\"hidden\" name=\"_wpcf7_version\" value=\"6.1.6\" \/><input type=\"hidden\" name=\"_wpcf7_locale\" value=\"en_US\" \/><input type=\"hidden\" name=\"_wpcf7_unit_tag\" value=\"wpcf7-f96-o1\" \/><input type=\"hidden\" name=\"_wpcf7_container_post\" value=\"0\" \/><input type=\"hidden\" name=\"_wpcf7_posted_data_hash\" value=\"\" \/>\n<\/fieldset>\n<div class=\"notify-form\">\n\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"your-email\"><input size=\"40\" maxlength=\"400\" class=\"wpcf7-form-control wpcf7-email wpcf7-validates-as-required wpcf7-text wpcf7-validates-as-email\" autocomplete=\"email\" aria-required=\"true\" aria-invalid=\"false\" placeholder=\"Get the latest drop\" value=\"\" type=\"email\" name=\"your-email\" \/><\/span>\n\t<\/p>\n\t<p> &nbsp;\n\t<\/p>\n\t<div class=\"acceptance\">\n\t\t<p>We use the details you submit to review your application and to contact you about appearing on PharmaTalks. If we go ahead, we will agree the terms of the recording with you separately, including the permissions we need to publish the episode. See the Privacy Policy for how we handle your data and the rights you have.\n\t\t<\/p>\n\t\t<p> &nbsp;\n\t\t<\/p>\n\t\t<p><span class=\"wpcf7-form-control-wrap\" data-name=\"acceptance-554\"><span class=\"wpcf7-form-control wpcf7-acceptance\"><span class=\"wpcf7-list-item\"><label><input type=\"checkbox\" name=\"acceptance-554\" value=\"1\" aria-invalid=\"false\" \/><span class=\"wpcf7-list-item-label\">I confirm I have read the <a href=\"\/privacy-policy\/\" style=\"text-decoration:underline\">Privacy Policy<\/a> and understand how Viseven Europe O\u00dc will process my personal data.<\/span><\/label><\/span><\/span><\/span><span class=\"wpcf7-form-control-wrap\" data-name=\"marketing_status\"><span class=\"wpcf7-form-control wpcf7-acceptance optional\"><span class=\"wpcf7-list-item\"><label><input type=\"checkbox\" name=\"marketing_status\" value=\"1\" aria-invalid=\"false\" \/><span class=\"wpcf7-list-item-label\">I would like to receive marketing communications from Viseven Europe O\u00dc and its Affiliates.<\/span><\/label><\/span><\/span><\/span>\n\t\t<\/p>\n\t<\/div>\n\t<p> &nbsp;\n\t<\/p>\n\t<p><span class=\"submit\"><input class=\"wpcf7-form-control wpcf7-submit has-spinner\" type=\"submit\" value=\"Notify me\" \/><\/span>\n\t<\/p>\n<\/div>\n<input class=\"wpcf7-form-control wpcf7-hidden\" value=\"Pharma Talks Newsletter\" type=\"hidden\" name=\"pageTitle\" \/>\n<input class=\"wpcf7-form-control wpcf7-hidden\" value=\"\" type=\"hidden\" name=\"pageUrl\" \/>\n<input class=\"wpcf7-form-control wpcf7-hidden\" id=\"offerType\" value=\"0\" type=\"hidden\" name=\"offerType\" \/><div class=\"wpcf7-response-output\" aria-hidden=\"true\"><\/div>\n<\/form>\n<\/div>\n\n<\/div><\/div>\n\n\n\n<div class=\"wp-block-group pt-split__col pt-split__col--right\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\">\n<div class=\"wp-block-group pt-split__col--right-container\"><div class=\"wp-block-group__inner-container is-layout-constrained wp-block-group-is-layout-constrained\">\n<section class=\"wp-block-pharmatalks-faq pt-faq\" style=\"--pt-faq-bg:#f0f2f000;--pt-faq-text:#082480;--pt-faq-title-align:left;--pt-faq-padding-top:51px;--pt-faq-padding-bottom:64px\"><div class=\"container\"><div class=\"pt-faq__inner\"><h2 class=\"pt-faq__title\">FAQ<\/h2><div class=\"pt-faq__list\"><details class=\"pt-faq__item\"><summary class=\"pt-faq__question\">What\u00a0is\u00a0Pharma Talks about?<\/summary><div class=\"pt-faq__answer\">Pharma Talks is a\u00a0pharma\u00a0podcast\u00a0where industry leaders discuss life sciences, commercialization, tech adoption,\u00a0digital transformation,\u00a0and leadership.\u00a0<\/div><\/details><details class=\"pt-faq__item\"><summary class=\"pt-faq__question\">Who\u00a0are\u00a0Pharma Talks\u00a0for?<\/summary><div class=\"pt-faq__answer\">This\u00a0pharma\u00a0marketing\u00a0podcast\u00a0is for life sciences professionals, pharma leaders, marketers, medical teams, and innovators who want to grow and refuse to accept the industry status quo.\u00a0<\/div><\/details><details class=\"pt-faq__item\"><summary class=\"pt-faq__question\">Who is the Pharma Talks host?\u00a0<\/summary><div class=\"pt-faq__answer\">This\u00a0pharmaceutical\u00a0podcast\u00a0is hosted by Nataliya Andreychuk,\u00a0founder and CEO of\u00a0Viseven, a global company that helps life sciences brands\u00a0reach\u00a0HCPs and patients\u00a0faster with\u00a0compliant\u00a0and impactful\u00a0content. She is also a LinkedIn voice in the industry, a member of the Forbes Agency Council, and a frequent speaker at industry events. Nataliya brings more than 20 years of experience in marketing and life sciences.\u00a0<\/div><\/details><details class=\"pt-faq__item\"><summary class=\"pt-faq__question\">Can I become a guest\u00a0at\u00a0Pharma Talks?<\/summary><div class=\"pt-faq__answer\">If you have experience\u00a0in pharma\u00a0and life sciences\u00a0or have founded a\u00a0brand, platform, or media, you can apply to be a guest and share your story with our audience.\u00a0<\/div><\/details><\/div><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What\u00a0is\u00a0Pharma Talks about?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Pharma Talks is a\u00a0pharma\u00a0podcast\u00a0where industry leaders discuss life sciences, commercialization, tech adoption,\u00a0digital transformation,\u00a0and leadership.\u00a0\"}},{\"@type\":\"Question\",\"name\":\"Who\u00a0are\u00a0Pharma Talks\u00a0for?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This\u00a0pharma\u00a0marketing\u00a0podcast\u00a0is for life sciences professionals, pharma leaders, marketers, medical teams, and innovators who want to grow and refuse to accept the industry status quo.\u00a0\"}},{\"@type\":\"Question\",\"name\":\"Who is the Pharma Talks host?\u00a0\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This\u00a0pharmaceutical\u00a0podcast\u00a0is hosted by Nataliya Andreychuk,\u00a0founder and CEO of\u00a0Viseven, a global company that helps life sciences brands\u00a0reach\u00a0HCPs and patients\u00a0faster with\u00a0compliant\u00a0and impactful\u00a0content. She is also a LinkedIn voice in the industry, a member of the Forbes Agency Council, and a frequent speaker at industry events. Nataliya brings more than 20 years of experience in marketing and life sciences.\u00a0\"}},{\"@type\":\"Question\",\"name\":\"Can I become a guest\u00a0at\u00a0Pharma Talks?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"If you have experience\u00a0in pharma\u00a0and life sciences\u00a0or have founded a\u00a0brand, platform, or media, you can apply to be a guest and share your story with our audience.\u00a0\"}}]}<\/script><\/div><\/div><\/section>\n<\/div><\/div>\n<\/div><\/div>\n<\/div><\/div><\/section>\n","protected":false},"excerpt":{"rendered":"","protected":false},"featured_media":1019,"template":"","meta":{"pt_page_bg_color":"#eff2ef","pt_page_bg_image_id":567,"pt_page_bg_image_url":"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/04\/Rectangle-1399-4.webp","pt_page_bg_image_size":"cover","pt_page_bg_image_position":"center","pt_page_bg_image_repeat":"no-repeat","pt_page_bg_fixed":true,"pt_page_text_color":""},"episode_topic":[],"class_list":["post-1018","episode","type-episode","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Omnichannel Isn&#039;t a Tech Problem: Yacin Marzouki on Pharma<\/title>\n<meta name=\"description\" content=\"Yacin Marzouki on why pharma&#039;s omnichannel struggles come from fragmented ownership, not missing technology \u2014 and what asking HCPs the wrong question costs.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-talks.com\/episodes\/pharma-omnichannel-engagement\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Omnichannel Isn&#039;t a Tech Problem: Yacin Marzouki on Pharma\" \/>\n<meta property=\"og:description\" content=\"Yacin Marzouki on why pharma&#039;s omnichannel struggles come from fragmented ownership, not missing technology \u2014 and what asking HCPs the wrong question costs.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-talks.com\/episodes\/pharma-omnichannel-engagement\/\" \/>\n<meta property=\"og:site_name\" content=\"PharmaTalks\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-03T14:54:40+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/09\/Podcast-How-Pharma-Should-Rethink-and-Mature-Its-Omnichannel-Engagement-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-talks.com\\\/episodes\\\/pharma-omnichannel-engagement\\\/\",\"url\":\"https:\\\/\\\/pharma-talks.com\\\/episodes\\\/pharma-omnichannel-engagement\\\/\",\"name\":\"Omnichannel Isn't a Tech Problem: Yacin Marzouki on Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-talks.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-talks.com\\\/episodes\\\/pharma-omnichannel-engagement\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-talks.com\\\/episodes\\\/pharma-omnichannel-engagement\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/pharma-talks.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/Podcast-How-Pharma-Should-Rethink-and-Mature-Its-Omnichannel-Engagement-1.png\",\"datePublished\":\"2025-12-19T05:07:00+00:00\",\"dateModified\":\"2026-09-03T14:54:40+00:00\",\"description\":\"Yacin Marzouki on why pharma's omnichannel struggles come from fragmented ownership, not missing technology \u2014 and what asking HCPs the wrong question costs.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-talks.com\\\/episodes\\\/pharma-omnichannel-engagement\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-talks.com\\\/episodes\\\/pharma-omnichannel-engagement\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-talks.com\\\/episodes\\\/pharma-omnichannel-engagement\\\/#primaryimage\",\"url\":\"https:\\\/\\\/pharma-talks.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/Podcast-How-Pharma-Should-Rethink-and-Mature-Its-Omnichannel-Engagement-1.png\",\"contentUrl\":\"https:\\\/\\\/pharma-talks.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/Podcast-How-Pharma-Should-Rethink-and-Mature-Its-Omnichannel-Engagement-1.png\",\"width\":1200,\"height\":675},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-talks.com\\\/episodes\\\/pharma-omnichannel-engagement\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/pharma-talks.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Episodes\",\"item\":\"https:\\\/\\\/pharma-talks.com\\\/episodes\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Omnichannel Isn&#8217;t a Tech Problem: Yacin Marzouki on Pharma\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-talks.com\\\/#website\",\"url\":\"https:\\\/\\\/pharma-talks.com\\\/\",\"name\":\"Pharmatalks dev\",\"description\":\"Exploring Pharma &amp; Life Sciences Podcasts\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-talks.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Omnichannel Isn't a Tech Problem: Yacin Marzouki on Pharma","description":"Yacin Marzouki on why pharma's omnichannel struggles come from fragmented ownership, not missing technology \u2014 and what asking HCPs the wrong question costs.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-talks.com\/episodes\/pharma-omnichannel-engagement\/","og_locale":"en_US","og_type":"article","og_title":"Omnichannel Isn't a Tech Problem: Yacin Marzouki on Pharma","og_description":"Yacin Marzouki on why pharma's omnichannel struggles come from fragmented ownership, not missing technology \u2014 and what asking HCPs the wrong question costs.","og_url":"https:\/\/pharma-talks.com\/episodes\/pharma-omnichannel-engagement\/","og_site_name":"PharmaTalks","article_modified_time":"2026-09-03T14:54:40+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/09\/Podcast-How-Pharma-Should-Rethink-and-Mature-Its-Omnichannel-Engagement-1.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/pharma-talks.com\/episodes\/pharma-omnichannel-engagement\/","url":"https:\/\/pharma-talks.com\/episodes\/pharma-omnichannel-engagement\/","name":"Omnichannel Isn't a Tech Problem: Yacin Marzouki on Pharma","isPartOf":{"@id":"https:\/\/pharma-talks.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-talks.com\/episodes\/pharma-omnichannel-engagement\/#primaryimage"},"image":{"@id":"https:\/\/pharma-talks.com\/episodes\/pharma-omnichannel-engagement\/#primaryimage"},"thumbnailUrl":"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/09\/Podcast-How-Pharma-Should-Rethink-and-Mature-Its-Omnichannel-Engagement-1.png","datePublished":"2025-12-19T05:07:00+00:00","dateModified":"2026-09-03T14:54:40+00:00","description":"Yacin Marzouki on why pharma's omnichannel struggles come from fragmented ownership, not missing technology \u2014 and what asking HCPs the wrong question costs.","breadcrumb":{"@id":"https:\/\/pharma-talks.com\/episodes\/pharma-omnichannel-engagement\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-talks.com\/episodes\/pharma-omnichannel-engagement\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-talks.com\/episodes\/pharma-omnichannel-engagement\/#primaryimage","url":"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/09\/Podcast-How-Pharma-Should-Rethink-and-Mature-Its-Omnichannel-Engagement-1.png","contentUrl":"https:\/\/pharma-talks.com\/wp-content\/uploads\/2026\/09\/Podcast-How-Pharma-Should-Rethink-and-Mature-Its-Omnichannel-Engagement-1.png","width":1200,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-talks.com\/episodes\/pharma-omnichannel-engagement\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pharma-talks.com\/"},{"@type":"ListItem","position":2,"name":"Episodes","item":"https:\/\/pharma-talks.com\/episodes\/"},{"@type":"ListItem","position":3,"name":"Omnichannel Isn&#8217;t a Tech Problem: Yacin Marzouki on Pharma\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/pharma-talks.com\/#website","url":"https:\/\/pharma-talks.com\/","name":"Pharmatalks dev","description":"Exploring Pharma &amp; Life Sciences Podcasts","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-talks.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"_links":{"self":[{"href":"https:\/\/pharma-talks.com\/?rest_route=\/wp\/v2\/episode\/1018","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-talks.com\/?rest_route=\/wp\/v2\/episode"}],"about":[{"href":"https:\/\/pharma-talks.com\/?rest_route=\/wp\/v2\/types\/episode"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pharma-talks.com\/?rest_route=\/wp\/v2\/media\/1019"}],"wp:attachment":[{"href":"https:\/\/pharma-talks.com\/?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1018"}],"wp:term":[{"taxonomy":"episode_topic","embeddable":true,"href":"https:\/\/pharma-talks.com\/?rest_route=%2Fwp%2Fv2%2Fepisode_topic&post=1018"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}